Ann Jackson-Shrouder, MBA, CPP, CQA

Advise biotechnology and life sciences organizations on procurement transformation, CDMO strategy, and contract negotiation to support clinical and commercial scale. • Partner with executive teams to design and implement procurement operating models, governance frameworks, and supplier strategies • Lead CDMO sourcing, contract negotiation, and supplier selection to support development and manufacturing programs • Provide strategic advisory across sourcing, supplier risk management, and operational restructuring • Support organizations transitioning from early-stage to commercialization with scalable procurement infrastructure

Joined Aurinia during its transition from a development-stage biotech into a commercial pharmaceutical organization and was promoted into executive leadership after building the company’s first enterprise procurement function from the ground up. Served as a strategic advisor to the C-suite with accountability for enterprise spend governance, scalability, and operational readiness in a regulated commercial environment. Built and scaled enterprise-wide procurement function supporting transition from late-stage clinical development to commercial operations; managed $500M+ global spend. • Designed and implemented end-to-end Source-to-Pay (S2P) and Contract Lifecycle Management (CLM) frameworks (Cobblestone, NetSuite), improving compliance, audit readiness, and operational efficiency • Led global CRO and CDMO sourcing strategy, including RFP/RFQ processes, supplier selection, and negotiation of MSAs, SOWs, Supply, and Quality Agreements • Delivered $50M+ in cost savings and enterprise value through structured sourcing, demand management, and supplier consolidation • Established enterprise supplier governance and risk management program, including KPIs, scorecards, and executive reporting • Built procurement function from inception, including organizational design, policies, and procedures • Partnered with Finance, Legal, Clinical Development, Quality, and Technical Operations to support budgeting, forecasting, compliance, and commercialization readiness

Recruited to design and launch Aurinia’s procurement function at a time when no formal sourcing, contracting, or spend governance existed, laying the foundation for enterprise scalability and future commercialization. Established Aurinia’s first formal procurement and strategic sourcing organization, creating policies, processes, and governance aligned with FDA and SOX compliance. Spearheaded enterprise-wide CLM implementation, replacing manual contracting with standardized workflows and controls; reduced contract cycle time by 40% and improved vendor onboarding and compliance. Delivered $40M+ in cost savings through vendor consolidation, demand planning, and negotiation of high-value contracts supporting clinical trials, R&D programs, and early commercial preparation. Introduced performance-based supplier scorecards, increasing accountability and improving supplier service levels by 50%. Implemented sourcing policies and spend controls that reduced rogue spend by 30% and significantly improved audit readiness across global procurement activities.

Led global procurement transformation and contract management across a growing biologics organization. • Centralized decentralized procurement into a governed enterprise sourcing model • Led negotiation of complex manufacturing, supply, and quality agreements supporting biologics production • Managed CDMO and external manufacturing relationships to ensure supply continuity and compliance • Implemented KPI-driven supplier governance improving supplier performance, reliability, and compliance by 50% • Served as procurement lead for contract management, aligning legal, quality, and operational requirements

• Restructured procurement and materials management operations across 22 plasma centers • Negotiated manufacturing and supply agreements delivering up to 50% cost reductions • Strengthened GMP-aligned materials governance and supply continuity strategies • Improved inventory management and operational efficiency to enhance cash flow and reduce excess inventory • Supported organizational readiness for acquisition integration and operational alignment

Recruited to restructure and professionalize Biotest’s corporate procurement function, transitioning a fragmented, site-driven buying model into a centralized, controlled sourcing organization supporting 22 plasma collection centers in a highly regulated manufacturing environment. Led the end-to-end restructuring of procurement and sourcing, establishing centralized governance, standardized buying processes, and cross-site coordination to ensure continuity of supply and regulatory compliance. Owned procurement for raw materials, indirect materials, soft goods, and services across all plasma centers, aligning facility buyers to production schedules, demand forecasts, and inventory requirements. Directed supplier qualification and sourcing initiatives, leading cross-functional project teams to qualify raw materials and components and execute contracts with favorable commercial and legal terms. Drove measurable cost savings and risk reduction through supplier rationalization, competitive sourcing, and contract standardization while improving service reliability across all sites. Partnered closely with Operations, Quality, and Finance to strengthen procurement controls, improve visibility to spend, and support uninterrupted plasma collection and production operations.

Selected by senior leadership to step into the Manager of Procurement role to centralize and strengthen procurement and sourcing within a regulated pharmaceutical manufacturing environment. Led procurement for APIs, excipients, and strategic commodities, ensuring supply continuity, inventory optimization, and compliance. Transformed a decentralized procurement model into a centralized function, improving governance, spend visibility, and execution. Delivered $3M+ in annual cost savings through strategic supplier negotiations and sourcing initiatives. Established KPI-driven supplier and inventory management, leading monthly performance reporting and continuous improvement efforts. Qualified and implemented 80%+ of strategic suppliers through the Supplier Material Evaluation Program, ensuring quality and regulatory compliance.

Promoted into a critical role to lead enterprise programs during a period of increased launch activity and supply complexity. Led cross-functional execution of new product launches, manufacturing transfers, and alternate API and excipient supplier programs. Partnered with Manufacturing, Quality, Supply Chain, and Regulatory teams to accelerate timelines and reduce supply risk. Delivered complex initiatives on or ahead of schedule, supporting uninterrupted production and faster time to market.